Selling the software business to Frazier Healthcare Partners will allow the respiratory device maker to shift more resources ...

July 7 (Reuters) - ResMed said on Tuesday it would sell its software business MatrixCare to private equity firm Frazier ...

Sharpens Resmed’s focus on high-growth sleep and connected care marketsSAN DIEGO, July 07, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep ...

ResMed is selling its MatrixCare home-health software unit to Frazier Healthcare Partners for $490m in cash to focus on sleep and breathing care.

Frazier Healthcare Partners announced on Tuesday it has entered into a definitive agreement to acquire MatrixCare from Resmed (RMD). The company said MatrixCare provides cloud-based EHR software ...

ResMed Inc (ASX: RMD) announces sale of MatrixCare for $490m, plans capital return, and reaffirms FY26 guidance.

Resmed remains the best performer of biotech's Big Four, but some investors aren't sleeping tight after last week's $700 ...

Frazier Healthcare Partners ("Frazier"), a private equity firm focused exclusively on the healthcare industry, today announced it has entered into a definitive agreement to acquire MatrixCare (the ...

Resmed ( (RMD)) has shared an update. On July 7, 2026, Resmed announced a definitive agreement to sell its MatrixCare business to private equity firm Frazier Healthcare Partners, in a move designed to ...

Resmed said it would sell its MatrixCare business to Frazier Healthcare Partners, a health-care focused private equity firm, for $490 million. Resmed, a global medical equipment company, said it ...

Selling the unit, which provides an EHR for post-acute care, will allow the respiratory device maker to shift more resources ...